The story of Sildenafil presents a complex picture for those considering investment. While the initial introduction generated significant profits, the lapse of its patent opened the floodgates to off-brand competitors, dramatically eroding sales. This poses a particular dilemma for firms banking on related blockbuster offerings, suggesting that a u

The history of Viagra, and its creator copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in sales , its patent expiration created a flood of knock-off medications, significantly eroding its dominance. While specific businesses may seek to capitalize on related treatments , the current landscape